Q4 2017 Peregrine Pharmaceuticals Inc Earnings Call
Llamada en conferencia Peregrine Pharmaceuticals Inc
Peregrine Pharmaceuticals Inc Conference call or earnings call will be held on 14-jul-2017 During the earnings conference call's session Peregrine Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Peregrine Pharmaceuticals Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a biopharmaceutical company committed to improving the lives of patients by delivering high quality pharmaceutical products through our contract manufacturing business and through advancing and licensing our novel, development-stage immunotherapy products. Avid Bioservices, Inc. ("Avid") is a contract development and manufacturing organization ("CDMO") and a wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc. ("Peregrine"). In June 2016, we announced a new corporate strategy to achieve profitability within two (2) years (during the quarter ending July 31, 2018), and at the same time, refocus our internal drug development efforts on small, early stage clinical trials designed to attract partnering interest in our investigational products.Leer más Llamada en conferencia